GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties ...

With flu vaccinations down and holiday travel on the way, experts worry that things may look much worse in the weeks ahead.

Invivyd said proceeds will support preparation for a potential VYD2311 launch and broader pipeline development.

In June 2024, EPKINLY monotherapy was granted accelerated approval by the FDA for the treatment of R/R FL following two or more lines of systemic therapy. With the results from the confirmatory Phase ...

Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...

The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...

After that, "most people recommend wearing a mask or having some sort of protective isolation for about five to seven days," ...

Abbott said on Thursday it would buy cancer test maker Exact Sciences in an up to $23 billion deal, bolstering the medical ...

Abbott is getting into the cancer-testing game with its $21 billion acquisition of Cologuard test maker Exact Sciences.

Millions of people worldwide continue to experience lingering symptoms after COVID-19, a condition known as long COVID. These ...